UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 204

Sortiert nach

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (2), p.175

2019

Volltextzugriff (PDF)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis

Frontiers in immunology, 2023-05, Vol.14, p.1162796-1162796

2023

Volltextzugriff (PDF)

Long-Term Outcomes of Outpatient Oral Food Challenges

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB166-AB166

2019

Volltextzugriff (PDF)

Global climate perturbations during the Permo-Triassic mass extinctions recorded by continental tetrapods from South Africa

Gondwana research, 2016-09, Vol.37, p.384-396

2016

Volltextzugriff (PDF)

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Gut, 2021-04, Vol.70 (4), p.635

2021

Volltextzugriff (PDF)

Recommendations for observational studies of comorbidity in multiple sclerosis

Neurology, 2016-04, Vol.86 (15), p.1446

2016

Volltextzugriff (PDF)

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

Brain (London, England : 1878), 2023-06, Vol.146 (6), p.2316-2331

2023

Volltextzugriff (PDF)

Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Gastroenterology, 2021-04, Vol.160 (5), p.1452-1460.e21

2021

Volltextzugriff (PDF)

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2020-12, Vol.19 (12), p.988-997

2020

Volltextzugriff (PDF)

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12576

2023

Volltextzugriff (PDF)

No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry

Multiple sclerosis, 2024-08, Vol.30 (9), p.13524585241240406-1220

2024

Volltextzugriff (PDF)

Circulating Soluble CD163, Associations With Cardiovascular Outcomes and Mortality, and Identification of Genetic Variants in Older Individuals: The Cardiovascular Health Study

Journal of the American Heart Association, 2022-11, Vol.11 (21), p.e024374-e024374

2022

Volltextzugriff (PDF)

Practical utility of amyloid and FDG-PET in an academic dementia center

Neurology, 2014-01, Vol.82 (3), p.230

2014

Volltextzugriff (PDF)

B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (39), p.E4119-E4126

2014

Volltextzugriff (PDF)

Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes

Diabetes (New York, N.Y.), 2021-05, Vol.70 (5), p.1038-1050

2021

Volltextzugriff (PDF)

Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET

European journal of nuclear medicine and molecular imaging, 2024-07, Vol.51 (8), p.2283-2292

2024

Volltextzugriff (PDF)

Aggressive multiple sclerosis (2): Treatment

Multiple Sclerosis Journal, 2020-08, Vol.26 (9), p.1045-1063

2020

Volltextzugriff (PDF)

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients

Journal of neurology, neurosurgery and psychiatry, 2014-03, Vol.85 (3), p.266-273

2014

Volltextzugriff (PDF)

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

Gut, 2017-04, Vol.66 (4), p.588

2017

Volltextzugriff (PDF)

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

Allergy (Copenhagen), 2021-03, Vol.76 (3), p.735-750

2021

Volltextzugriff (PDF)

Development of the Crohn's disease digestive damage score, the Lémann score

Inflammatory bowel diseases, 2011-06, Vol.17 (6), p.1415-1422

2011

Volltextzugriff (PDF)

Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia

JAMA neurology, 2018-03, Vol.75 (3), p.342

2018

Volltextzugriff (PDF)

forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity

Proceedings of the National Academy of Sciences - PNAS, 2012-07, Vol.109 (31), p.12286-12293

2012

Volltextzugriff (PDF)

The Risk of Failing Oral Food Challenge to Baked Egg and Milk Increases with Wheat Flour Replacers

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB136-AB136

2016

Volltextzugriff (PDF)

26 – 50 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(186)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis

Long-Term Outcomes of Outpatient Oral Food Challenges

Global climate perturbations during the Permo-Triassic mass extinctions recorded by continental tetrapods from South Africa

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Recommendations for observational studies of comorbidity in multiple sclerosis

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes

No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry

Circulating Soluble CD163, Associations With Cardiovascular Outcomes and Mortality, and Identification of Genetic Variants in Older Individuals: The Cardiovascular Health Study

Practical utility of amyloid and FDG-PET in an academic dementia center

B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS

Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes

KDM5A mutations identified in autism spectrum disorder using forward genetics

Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET

Aggressive multiple sclerosis (2): Treatment

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

Development of the Crohn's disease digestive damage score, the Lémann score

Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia

forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity

The Risk of Failing Oral Food Challenge to Baked Egg and Milk Increases with Wheat Flour Replacers

Suchergebnisse filtern